Animal studies of Parkinson’s disease have revealed that rTMS decreased the levels of cyclooxygenase-2 and tumor necrosis factor-α in rat substantia nigra [48], improved motor functions and preserved the function of dopamine neurons [50]. Here, PTGS2 is linked to Parkinson disease.